MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2025.115394

Медицинская библиотека · International immunopharmacology · 2025

Anemoside B4 improves cardiac function after myocardial infarction by regulating HTR2A/ERK pathway.

Lv Mei, Sun Qing, Yu Yilin, Yu Dawei

СтатьяПеревод в очереди

Аннотация

PURPOSE: Assessing the role of anemoside B4 (B4) in myocardial infarction (MI) and the regulatory mechanism was the purpose of this study.

METHODS

We established MI rat model through ligation of the left anterior descending coronary artery and cardiomyocyte injury model through H2O2 stimulation. The effects of B4 on cardiac function in MI rat model were assessed utilizing echocardiography, histological staining, and western blot. In vitro, CCK-8, flow cytometer, and ELISA were utilized for assessing B4's effects on cardiomyocyte viability, apoptosis, inflammatory response. The network pharmacology was applied for exploring B4's mechanism in MI.

RESULTS

In vivo, B4 alleviated myocardial injury, as evidenced by improving cardiac function parameters, reduced collagen synthesis and deposition, preserved cardiac structure, and decreased apoptosis, inflammation response, and oxidative stress. In vitro, B4 enhanced cell viability and inhibited oxidative stress, apoptosis, and inflammation response. Mechanistically, based on molecular docking, B4-HTR2A complex was found to have a good binding activity. Furthermore, B4 reduced HTR2A and p-ERK/ERK protein expression in MI rat model and cardiomyocyte injury model. More importantly, the effects of B4 on cardiomyocyte viability, oxidative stress, apoptosis, and inflammation were reversed by HTR2A overexpression. HTR2A knockdown alleviated H2O2-induced oxidative stress, apoptosis, and inflammation.

CONCLUSION

B4 protected cardiomyocytes and alleviated cardiac dysfunction, oxidative stress, inflammation, and apoptosis, which were partly mediated by inhibiting HTR2A/ERK pathway. B4 may be a promising therapeutic drug for MI treatment.

Для цитирования: Lv Mei, Sun Qing, Yu Yilin, Yu Dawei. Anemoside B4 improves cardiac function after myocardial infarction by regulating HTR2A/ERK pathway.. International immunopharmacology. 2025. DOI: 10.1016/j.intimp.2025.115394.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.